BIMTUVIQ
DEAD

Serial Number

97878111

Owner

AMGEN INC.

Attorney

Elsa D. Lemoine

Filing Date

Apr 7, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BIMTUVIQ Trademark

Serial Number: 97878111

BIMTUVIQ is a trademark filed by AMGEN INC. on April 7, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

AMGEN INC. (820 trademarks)

THOUSAND OAKS, CA 91320

Entity Type: 03

Trademark Details

Filing Date

April 7, 2023

Registration Date

Not Registered

Published for Opposition

August 13, 2024

Goods & Services

Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of gastric and gastro-esophageal diseases, conditions or maladies

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 11, 2024 ETOP
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Nov 29, 2024 MAB5
ABANDONMENT - AFTER PUBLICATION
Nov 29, 2024 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Nov 26, 2024 EXAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 12, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 2, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 19, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 19, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 7, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 5, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2023 NWOS
NEW APPLICATION ENTERED
Apr 11, 2023 NWAP